Now on

The European Commission grants Orphan Drug Designation to 4,6,4’–trimethylangelicin for the treatment of Cystic Fibrosis

The European Commission grants Orphan Drug Designation to 4,6,4’–trimethylangelicin for the treatment of Cystic Fibrosis

RP announcement - read more
Thanks to all Rare Runners who have run with us and for us

Thanks to all Rare Runners who have run with us and for us

RP announcement - read more
Rare Partners presents a poster on Rapamycin project

Rare Partners announces the presentation of a poster at the ECRD meeting 2012

RP announcement - read more
Rare Partners announces a three parties alliance for thalassemia

Rare Partners announces a three parties alliance for the use of rapamycin in thalassemic patients, based on the research carried out by Professor Roberto Gambari and coworkers at the University of Ferrara.

RP announcement - read more
Rare Partners and Milan Marathon 2015

Rare Partners and Milan Marathon 2015, #runandimagetofly a record edition

News - read more